Tracheal tunica adventitia invasion after lobectomy in patients with non-small cell lung cancer
Open Access
- 14 August 2023
- Vol. 174 (4) , 971-978
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2022
- Postoperative Radiation Therapy Should Be Used for Completely Resected Stage III-N2 NSCLC in Select PatientsJournal of Thoracic Oncology, 2022
- A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2022
- Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trialThe Lancet, 2021
- Lung cancerThe Lancet, 2021
- Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant ChemotherapyJAMA Oncology, 2021
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trialThe Lancet, 2016
- Unsuspected residual disease at the resection margin after surgery for lung cancer: fate of patients after long-term follow-upEuropean Journal of Cardio-Thoracic Surgery, 2003
- Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2002
- Prognostic implications of a positive bronchial resection marginEuropean Journal of Cardio-Thoracic Surgery, 2000